{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:18:28Z","timestamp":1791163108951,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","award":["2022ZD01004"],"award-info":[{"award-number":["2022ZD01004"]}],"id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B21024"],"award-info":[{"award-number":["B21024"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023ZQNZD01020044"],"award-info":[{"award-number":["2023ZQNZD01020044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241209"],"award-info":[{"award-number":["82241209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304213"],"award-info":[{"award-number":["82304213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J01706"],"award-info":[{"award-number":["2022J01706"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116710","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T19:03:53Z","timestamp":1715022233000},"page":"116710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["PDE5 inhibition mitigates heart failure in hyperlipidemia"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-8622","authenticated-orcid":false,"given":"Wuqing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihuang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7771-3584","authenticated-orcid":false,"given":"Sujun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116710_bib1","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2024.116710_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/eurjpc\/zwac290","article-title":"Association of genetically predicted lipid traits and lipid-modifying targets with heart failure","volume":"30","author":"Xiao","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.biopha.2024.116710_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1101\/gad.1992411","article-title":"Phospholipid homeostasis regulates lipid metabolism and cardiac function through SREBP signaling in Drosophila","volume":"25","author":"Lim","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2024.116710_bib4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCRESAHA.111.253104","article-title":"Dietary fat and heart failure: moving from lipotoxicity to lipoprotection","volume":"110","author":"Stanley","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.116710_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCRESAHA.120.317883","article-title":"Lipid profiles and heart failure risk: results from two prospective studies","volume":"128","author":"Wittenbecher","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.116710_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2019.04.011","article-title":"Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure","volume":"96","author":"Halade","year":"2019","journal-title":"Metab.\u00a0Clin. Exp."},{"key":"10.1016\/j.biopha.2024.116710_bib7","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s11010-021-04159-5","article-title":"Comprehensive plasma metabolomic and lipidomic analyses reveal potential biomarkers for heart failure","volume":"476","author":"Zhou","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2024.116710_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012621.pub2","article-title":"Phosphodiesterase 5 inhibitors for pulmonary hypertension","author":"Barnes","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2024.116710_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.10.003","article-title":"PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer","volume":"147","author":"Das","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116710_bib10","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/heartjnl-2017-312865","article-title":"Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?","volume":"104","author":"Hutchings","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2024.116710_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrcardio.2009.32","article-title":"Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications","volume":"6","author":"Kumar","year":"2009","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.116710_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tips.2014.05.003","article-title":"Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond","volume":"35","author":"Lukowski","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2024.116710_bib13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2021.01.045","article-title":"Association of phosphodiesterase-5 inhibitors versus alprostadil with survival in men with coronary artery disease","volume":"77","author":"Andersson","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.116710_bib14","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/heartjnl-2016-310746","article-title":"Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction","volume":"103","author":"Andersson","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2024.116710_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ejhf.662","article-title":"Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension","volume":"19","author":"Liu","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2024.116710_bib16","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/heartjnl-2015-309223","article-title":"Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality","volume":"102","author":"Anderson","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2024.116710_bib17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2011.05.004","article-title":"Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism?","volume":"22","author":"Armani","year":"2011","journal-title":"Trends Endocrinol. Metab.\u00a0TEM"},{"key":"10.1016\/j.biopha.2024.116710_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.niox.2013.10.006","article-title":"Phosphodiesterase 5 as target for adipose tissue disorders","volume":"35","author":"Colombo","year":"2013","journal-title":"Nitric Oxide\u00a0Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116710_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00395-012-0308-y","article-title":"Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo","volume":"107","author":"Westermann","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2024.116710_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2008.08.069","article-title":"Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload","volume":"53","author":"Nagayama","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.116710_bib21","first-page":"e535","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116710_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2024.116710_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116710_bib24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jacc.2009.07.024","article-title":"The adrenergic-fatty acid load in heart failure","volume":"54","author":"Opie","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.116710_bib25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacl.2021.05.005","article-title":"Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"15","author":"Nomura","year":"2021","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.biopha.2024.116710_bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCHEARTFAILURE.113.000521","article-title":"Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study","volume":"6","author":"Djousse","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.biopha.2024.116710_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2796.2011.02384.x","article-title":"Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality","volume":"270","author":"\u00d8ie","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.biopha.2024.116710_bib28","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1177\/2050640620944140","article-title":"Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats","volume":"8","author":"Brusilovskaya","year":"2020","journal-title":"U. Eur. Gastroenterol. J."},{"key":"10.1016\/j.biopha.2024.116710_bib29","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/01.CIR.0000159339.00703.22","article-title":"Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy","volume":"111","author":"Takahashi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116710_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pharmthera.2007.04.010","article-title":"Role of diacylglycerol kinase in cellular regulatory processes: a new regulator for cardiomyocyte hypertrophy","volume":"115","author":"Takeishi","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116710_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.05.029","article-title":"Metabolism and atherogenic disease association of lysophosphatidylcholine","volume":"208","author":"Schmitz","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2024.116710_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152841","article-title":"Radiation-induced lipoprotein-associated phospholipase A2 increases lysophosphatidylcholine and induces endothelial cell damage","volume":"458","author":"Kim","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2024.116710_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911997","article-title":"Plasma campesterol is positively associated with carotid plaques in asymptomatic subjects","volume":"23","author":"Nunes","year":"2022","journal-title":"Int. J. Mol. Sci."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2025.118534","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:38:07Z","timestamp":1778693887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224005948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"alternative-id":["S0753332224005948"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116710","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDE5 inhibition mitigates heart failure in hyperlipidemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116710"}}